Ignite Creation Date:
2025-12-24 @ 11:57 PM
Ignite Modification Date:
2026-03-08 @ 1:58 AM
Study NCT ID:
NCT02890758
Status:
COMPLETED
Last Update Posted:
2023-02-21
First Post:
2016-09-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803
Sponsor:
Brenda Cooper, MD
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Acute Myeloid Leukemia | View |
| None | Myelodysplastic Syndrome | View |
| None | Acute Lymphoblastic Leukemia | View |
| None | Chronic Myeloid Leukemia | View |
| None | Chronic Lymphocytic Leukemia | View |
| None | Non Hodgkin Lymphoma | View |
| None | Hodgkin Lymphoma | View |
| None | Myeloproliferative Syndromes | View |
| None | Plasma Cell Myeloma | View |
| None | Colon Carcinoma | View |
| None | Adenocarcinoma of Rectum | View |
| None | Soft Tissue Sarcoma | View |
| None | Ewing's Sarcoma | View |
| None | Rhabdomyosarcoma | View |